Small Molecule Targeted Anti-cancer Drug and Forecast Market

List of Tables
Table 1. Small Molecule Targeted Anti-cancer Drug Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Anti-cancer Drug Market Drivers in Global Market
Table 3. Small Molecule Targeted Anti-cancer Drug Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Anti-cancer Drug in Global Market
Table 5. Top Small Molecule Targeted Anti-cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Small Molecule Targeted Anti-cancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 30. Astrazeneca Company Summary
Table 31. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 32. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Astrazeneca Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 36. Novartis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Millennium Pharmaceuticals Company Summary
Table 39. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 40. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Millennium Pharmaceuticals Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 44. Bayer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Exelixis Company Summary
Table 47. Exelixis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 48. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Exelixis Key News & Latest Developments
Table 50. Abbvie Company Summary
Table 51. Abbvie Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 52. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Abbvie Key News & Latest Developments
Table 54. Boehringer-Ingelheim Company Summary
Table 55. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 56. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer-Ingelheim Key News & Latest Developments
Table 58. Eisai Company Summary
Table 59. Eisai Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 60. Eisai Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Eisai Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 64. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 68. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 72. Roche Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Bettapharma Company Summary
Table 75. Bettapharma Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 76. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Bettapharma Key News & Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Anti-cancer Drug Segment by Type in 2022
Figure 2. Small Molecule Targeted Anti-cancer Drug Segment by Application in 2022
Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Anti-cancer Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue in 2022
Figure 8. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 16. US Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 20. Germany Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 28. China Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eisai Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)